Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Merck
Mallinckrodt
Moodys
McKesson

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR ORABASE HCA


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Orabase Hca

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02329600 ↗ Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus Completed Cairo University Phase 3 2013-06-01 The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets.
NCT02645656 ↗ Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF) Unknown status SVS Institute of Dental Sciences Phase 2 2013-12-01 Curcumin (diferuloylmethane) is the chief component of the spice turmeric and is derived from the rhizome of the East Indian plant Curcuma longa. Curcuma longais a member of the Zingiberacae (ginger) family of botanicals and is a perennial plant that is native to Southeast Asia. Turmeric contains a class of compounds known as the curcuminoids, comprised of curcumin, demethoxy curcumin and bisdemethoxycurcumin.
NCT03026478 ↗ Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus Unknown status Garlapati Komali Phase 2 2016-05-06 Oral Lichen Planus (OLP) is an autoimmune, chronic inflammatory mucocutaneous disease characterized by pain and burning sensation. The major types of OLP are the following: reticular, atrophic, erosive-ulcerative, bullous and pigmentous form.Its etiology remains unclear. The presence of auto-cytotoxic T cell clones in the lesions suggests the role of autoimmunity. Numerous treatment options of OLP include topical and systemic agents depending on severity of lesions . Topical corticosteroids abide the mainstay of therapy,and are widely accepted as the primary treatment of choice.Hence this study is designed to evaluate and compare the clinical efficacy of topical Clobetasol 0.05% in orabase and Betamethasone 0.05% in orabase in combination with Clotrimazole 1% in the management of symptomatic Oral Lichen Planus.
NCT03415165 ↗ Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus Unknown status Cairo University Early Phase 1 2018-01-03 Is topical application of green tea polyphenols buccal tablet more effective in treatment of patients with symptomatic oral lichen planus in comparison with topical application of corticosteroids and what is the most effective concentration of polyphenols
NCT03572959 ↗ Management of Pain in Oral Lichen Planus Completed Sherine Adel Nasry Phase 4 2016-12-27 Treating Oral Lichen Planus (OLP) is a big challenge for clinicians. Despite numerous existing remedies, to date no effective cure has been found, which is mainly attributed to the lack of understanding of the pathogenesis of the disease. The investigator's aim was comparing the effectiveness of topical steroids and diode laser in treating OLP patients. Twenty-four patients with OLP were allocated into two groups of twelve patients each. One group was treated with 970 nm diode laser applied twice weekly and the other group was treated with topical steroids applied four times per day. Patients were followed up for two months. Pain was recorded using the visual analog score (VAS) and the clinical signs and symptoms were recorded using the reticular, atrophic, erosive (RAE) sores. Pain and RAE records were taken before treatment, after treatment and after 2 months.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Orabase Hca

Condition Name

Condition Name for Orabase Hca
Intervention Trials
Oral Lichen Planus 6
Oral Submucous Fibrosis 1
Oral Ulcer Due to Benign Mucous Membrane Pemphioid 1
Oral Ulcer Due to Pemphius Vularis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Orabase Hca
Intervention Trials
Lichen Planus 6
Lichen Planus, Oral 6
Oral Ulcer 2
Ulcer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Orabase Hca

Trials by Country

Trials by Country for Orabase Hca
Location Trials
Egypt 3
India 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Orabase Hca

Clinical Trial Phase

Clinical Trial Phase for Orabase Hca
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Orabase Hca
Clinical Trial Phase Trials
Unknown status 5
Completed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Orabase Hca

Sponsor Name

Sponsor Name for Orabase Hca
Sponsor Trials
Cairo University 4
SVS Institute of Dental Sciences 1
Garlapati Komali 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Orabase Hca
Sponsor Trials
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Johnson and Johnson
McKinsey
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.